Suppr超能文献

[靶向白细胞介素-6治疗延缓类风湿关节炎患者关节结构损伤]

[IL-6 targeting therapy to retard structural joint damage in patients with rheumatoid arthritis].

作者信息

Nishimoto Norihiro

机构信息

Laboratory of Immune Regulation, Wakayama Medical University.

出版信息

Clin Calcium. 2009 Mar;19(3):425-31.

Abstract

Tocilizumab has been shown to have strong effect to retard the progression of structural joint damage in patients with rheumatoid arthritis. It was approved not only for signs and symptoms but also structural joint damage of rheumatoid arthritis in Japan. In this review, the efficacy, utility, positioning, and the future prospect will be discussed.

摘要

托珠单抗已被证明对延缓类风湿性关节炎患者关节结构损伤的进展具有显著效果。在日本,它不仅被批准用于治疗类风湿性关节炎的体征和症状,还被批准用于治疗关节结构损伤。在本综述中,将讨论其疗效、实用性、定位及未来前景。

相似文献

4
[MRA for therapy of rheumatoid arthritis].
Nihon Rinsho. 2005 Jan;63 Suppl 1:538-43.
5
Tocilizumab.托珠单抗。
MAbs. 2009 Sep-Oct;1(5):432-8. doi: 10.4161/mabs.1.5.9497. Epub 2009 Sep 10.
6
[IL-6 targetting therapy for inflammatory immune diseases].[白细胞介素-6靶向治疗炎症性免疫疾病]
Nihon Naika Gakkai Zasshi. 2006 Sep 10;95(9):1795-800. doi: 10.2169/naika.95.1795.
7
[IL-6 inhibitors for treatment of rheumatoid arthritis].用于治疗类风湿性关节炎的白细胞介素-6抑制剂
Nihon Naika Gakkai Zasshi. 2008 Oct 10;97(10):2413-7. doi: 10.2169/naika.97.2413.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验